Plea in Bombay High Court seeks Z+ security for Adar Poonawalla, his family

A writ petition on Wednesday has been filed in the Bombay High Court seeking Z plus security for Serum Institute of India CEO Adar Poonawalla and his family

Adar Poonawalla, CEO, Serum Institute
Adar Poonawalla, CEO, Serum Institute
ANI General News
2 min read Last Updated : May 06 2021 | 9:21 AM IST

A writ petition on Wednesday has been filed in the Bombay High Court seeking Z plus security for Serum Institute of India CEO Adar Poonawalla and his family.

The petitioner has said Poonawalla should be given Z plus security for himself and his family, and his assets should be protected keeping the threats which were made to Poonawallah as per media reports.

The plea requested the court to give order to Maharashtra government and Pune Police Commissioner to file an FIR in the matter based on the petitioner's complaint which he has already submitted.

He also requested that by the time the order on his petition comes, Poonawalla and his family should be given ample police protection and there should be police deployment at Serum institute and other properties of Poonawalla.

On May 2, in an interview to a London newspaper, Poonawalla had complained of receiving threats from politicians and "powerful men" demanding quick delivery of the COVID-19 vaccine that his firm has been producing.

Poonawalla had also complained of being "vilified and blamed", and hinted at starting a new vaccine production unit in the United Kingdom.

He had said he had received calls from "some of the most powerful men in India", including "Chief Ministers, heads of business conglomerates and others.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Serum Institute of IndiaBombay High CourtCoronavirus Vaccine

First Published: May 06 2021 | 8:56 AM IST

Next Story